Stock listing

Evotec Se

Selected listing: EVT · HAN · EUR · DE

Evotec Se (Hanover:EVT), Commercial Services. Latest release Sep 29, 2026: Evotec Announces Chief Scientific Officer Transition.

EVT:HANEURDEUpdated September 25, 2026

Ticker: Hanover:EVT
Asset type: Stock
Sector: Commercial Services
Industry: Miscellaneous Commercial Services
Exchange: Hanover
Currency: EUR

About Evotec Se

Evotec SE is a public company listed on the German market under the ticker EVT. The company collaborates with various partners to advance innovative therapies and improve patient outcomes.

Latest news from Evotec Se

Evotec Announces Chief Scientific Officer Transition

September 29, 2026

Evotec and Plectonic Enter Research Collaboration to Explore New Generation of T-Cell-Engaging Approaches for Solid Tumors

September 2, 2026

Evotec : Half-year report 2026, PDF (H1 Report 2026 English)

August 13, 2026

Evotec : Half-year report 2026, PDF (Interim Statement H1 2026 English)

August 13, 2026

Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases

August 6, 2026

All Evotec Se news →

Events

Replays

Evotec SE (EVO) Q2 2026 Earnings Call
Tue, Jul 14, 2026 · 08:00 AM ET
Watch
Evotec SE (EVO) Q1 2026 Earnings Call
Wed, May 06, 2026 · 08:00 AM ET
Watch
Evotec SE (EVO) Q4 2025 Earnings Call
Wed, Apr 08, 2026 · 08:00 AM ET
Watch

Research Evotec Se

Evotec Se company profile

View the public company page for Evotec Se on 6ix.

Evotec Se news

Read company news and market updates connected to Evotec Se.

Evotec Se investor events

Find investor webinars, events, and replay context for Evotec Se.